Study of common variants of the apolipoprotein E and lipoprotein lipase genes in patients with coronary heart disease and variable body mass index
In the present study, we evaluated the influence of lipoprotein lipase (LPL) and apolipoprotein (apo) E polymorphisms on lipid concentrations of 178 Greek men of similar age with coronary heart disease (CHD), but varying body mass index (BMI).
Patients were divided according to their BMI (in kg/m2) into three groups: lean (BMI=20–24.9), overweight (BMI=25–29.9), and obese (BMI ≥30). Polymorphisms of LPL (HindIII, S447X) and apo E (ε2, ε3, ε4), and lipid parameters were studied.
There was a negative correlation between BMI and high-density lipoprotein cholesterol (HDL-C) concentration (r=−0.272, p<0.001), as has already been described. Lean homozygotes for the HindIII(+) allele had higher HDL-C levels compared to lean homozygotes for the HindIII(−) allele (p=0.012). No correlation was found between S447X or apo E polymorphisms and BMI or plasma lipids in any group. Overweight men with the ε3/ε3 and SS genotypes had higher triglycerides concentration compared with overweight men with ε3/ε3 and SX (p=0.002).
The HindIII polymorphism alone may influence HDL-C concentration in lean men, in contrast to S447X alone, which has no influence on any lipid parameters. However, the S447X and apo E polymorphisms may have a synergetic effect and alter plasma triglyceride concentration in overweight men.
Key wordsApolipoprotein E Body mass index Coronary heart disease Lipids Lipoprotein lipase Polymorphism
- 12.Salinelli S, Lo JY, Mims MP, Zsigmond E, Smith LC, Chan L, 1996 Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor: functional importance of a properly folded surface loop covering the catalytic center. J Biol Chem 271: 21906–21913.CrossRefGoogle Scholar
- 14.Groenemeijer BE, Hallman MD, Reymer PW, et al, 1997 Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 95: 2628–2635.CrossRefGoogle Scholar
- 21.Peacock RE, Hamsten A, Nilsson-Ehle P, 1992 Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97: 171–185.CrossRefGoogle Scholar
- 32.Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ, 1998 Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18: 526–534.CrossRefGoogle Scholar
- 35.Xin X, Srinivasan SR, Chen W, Boerwinkle E, Berenson GS, 2003 Interaction effect of Serine447Stop variant of the lipoprotein lipase gene and C-514T variant of the hepatic lipase gene on serum triglyceride levels in young adults: the Bogalusa Heart Study. Metabolism 52: 1337–1342.CrossRefGoogle Scholar
- 48.Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE, 1992 Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97: 171–185.CrossRefGoogle Scholar
- 49.Heinzmann C, Kirchgessner T, Kwiterovich PO, et al, 1991 DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible associations with high-density lipoprotein levels. Hum Genet 86: 578–584.Google Scholar